Advertisement
Research Article Free access | 10.1172/JCI111616
Find articles by Lim, H. in: JCI | PubMed | Google Scholar
Find articles by Poh-Fitzpatrick, M. in: JCI | PubMed | Google Scholar
Find articles by Gigli, I. in: JCI | PubMed | Google Scholar
Published December 1, 1984 - More info
Irradiation of the forearms of two patients with erythropoietic protoporphyria and one patient with porphyria cutanea tarda resulted in an in vivo activation of the complement system, as assessed by diminution of the hemolytic titers of the third component of complement by 23-57%, and of the fifth component of complement (C5) by 19-47%. Such treatment also generated chemotactic activity for human polymorphonuclear cells; the chemotactic activity was stable at 56 degrees C and antigenically related to human C5. On Sephadex G-75 chromatography the chemotactic activity eluted with an apparent molecular weight of 15,000. These in vivo results extend our previous in vitro observation of photoactivation of complement in sera from patients with erythropoietic protoporphyria and porphyria cutanea tarda, and suggest that the complement system may participate in the pathogenesis of cutaneous phototoxicity in these patients.